logo
iolite Files Formal Complaint with Securities Regulatory Authority and Calls for the Immediate Resignation of Chairman Pierre Lépine and CEO & President Jean Martineau

iolite Files Formal Complaint with Securities Regulatory Authority and Calls for the Immediate Resignation of Chairman Pierre Lépine and CEO & President Jean Martineau

Yahoo30-06-2025
Significant Operational and Financial Issues, Disclosure Failures, and Problematic Leadership at Dynacor Group Inc. (TSX: DNG)
FREIENBACH, Switzerland, June 30, 2025--(BUSINESS WIRE)--iolite Partners Ltd. ("iolite"), the largest shareholder of Dynacor Group Inc. (TSX: DNG, "Dynacor"), announces that it has filed a formal complaint with the Quebec Autorité des marches financiers regarding potential disclosure violations by Dynacor. The complaint cites potential disclosure failures including in the lead-up to Dynacor's June 17, 2025 annual general meeting ("AGM") and in subsequent communications.
Despite significant use of company resources to secure votes, the narrow margins in the Chairman's (60.98%) and CEO's (73.77%) re-election demonstrate the absence of any true mandate or vote of confidence in Dynacor's leadership.
The full complaint calls for investigation into potential:
Undisclosed loss of key talent and resulting risks.
Large-scale dismissals and forced resignations of longstanding personnel in Peru — without reason, notice, and severance — followed by the hiring of unqualified individuals at inappropriate pay levels, exposing the Company to serious operational, legal, and financial risks.
Failure to disclose the material deterioration of Veta Dorada — the subsidiary that generates 100% of the Company's revenue — misleading investors about the true state of the business.
Issues regarding the credibility of Dynacor's international expansion narrative given the obvious deterioration of the core business and loss of key talent, used to justify both a contested capital increase in January 2025 and the re-election of directors at the AGM.
Failure to revise guidance despite clear evidence of operational decline.
iolite has filed this complaint in good faith, in the interest of all shareholders, to accelerate long-overdue leadership change at Dynacor and to ensure transparency and proper disclosure. The scope and severity of management's failures leave no credible reason for Messrs. Lépine and Martineau to remain in office; their continued presence exposes the Company to unacceptable operational, financial, and reputational risk.
At the June 17, 2025 AGM – and again in a June 19, 2025 press release – management celebrated past achievements, touted international expansion, and reaffirmed optimistic guidance even as key operating metrics seem to have deteriorated.
Barely a week later, on June 27, the Company issued a self-contradictory release announcing a "restructuring in Peru," allegedly triggered by "employee practices contrary to the Corporation's values and Code of Conduct," yet presented as part of a global growth plan requiring more head-office hiring. Management hired an external firm to review the evidently serious matter, but offered no explanation of what went wrong or why a review was necessary, leaving investors completely in the dark.
iolite remains convinced Dynacor has real potential and is undervalued: it is a leading niche player in an attractive market, with nearly half its market cap in cash and positive free cash flow through Q1 2025. But the status quo is untenable. Dynacor urgently needs competent, decisive leadership of unimpeachable integrity – leadership capable of restoring trust, stabilizing operations, and unlocking the Company's full value for every shareholder.
To those who understand the issues, the solution is obvious. iolite stands ready to help.
About iolite
Founded in 2011 iolite Capital is a Switzerland-based investment manager with a focus on hidden champions: good businesses at attractive valuations. iolite serves a select circle of private and institutional clients who share the same entrepreneurial mindset, are willing to invest for the long term, and who would like to have first-hand access to a dedicated portfolio manager with substantial and meaningful skin in the game. Using a private equity approach, iolite conducts deep fundamental research, constructively engages with management, and adopts a long-term investment horizon. For more information on iolite, please visit www.iolitecapital.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250630911429/en/
Contacts
iolite CapitalGwattstrasse 158808 Freienbach SZSwitzerland
Investor Relations+41 79 227 29 08dynacor@iolitecapital.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Who could lead Apple after Tim Cook
Who could lead Apple after Tim Cook

Yahoo

time38 minutes ago

  • Yahoo

Who could lead Apple after Tim Cook

There are no indications that Apple (AAPL) CEO Tim Cook is planning on leaving his role anytime soon. But the company's underwhelming AI developments have some questioning if it's time for new leadership. Yahoo Finance Tech Editor Dan Howley takes a closer look at some of the potential contenders. To watch more expert insights and analysis on the latest market action, check out more Market Domination. Related videos £50k in savings? Here's how to unlock up to £4.5k in passive income overnight Down 55% in 5 years, but this FTSE stock offers a 9.5% dividend yield for income investors! How will the Lloyds share price be affected by today's Supreme Court ruling? Meet the 75p dividend stock with a higher yield than Legal & General shares Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Trump Tariffs Stun Swiss Investors Ahead of Monday's Market Open
Trump Tariffs Stun Swiss Investors Ahead of Monday's Market Open

Yahoo

timean hour ago

  • Yahoo

Trump Tariffs Stun Swiss Investors Ahead of Monday's Market Open

(Bloomberg) -- Swiss stock investors are bracing for Monday's market reopening after US President Donald Trump slapped a punitive 39% export tariff on the country, among the highest in the world. The World's Data Center Capital Has Residents Surrounded An Abandoned Art-Deco Landmark in Buffalo Awaits Revival We Should All Be Biking Along the Beach Seeking Relief From Heat and Smog, Cities Follow the Wind NYC Mayor Adams Gives Bally's Bronx Casino Plan a Second Chance Trump's tariff rollout landed on a holiday, Swiss National Day, which means any market fallout will only be felt once trading resumes on Monday. While Trump's fresh tariff salvo left baseline rates unchanged for many of the US's trading partners, some like Canada and Switzerland got hit with significantly higher duties. Switzerland, known for its luxury watches, rich chocolates and banking giants, is one of the US's biggest trade partners. Last year, it exported more than $60 billion of goods to the US, ranging from pharmaceuticals and medical devices to Nespresso coffee. So the 39% tariff rate is likely to roil the market Monday even if some investors cling to the hope that it's just another one of Trump's negotiating ploys. 'Clearly, the Swiss market's first reaction will be negative,' said Andreas Wosol, head of Amundi SA's European equity value strategies. 'But then attention turns to negotiations. This is an announcement where Trump wants a reaction rather than to impose this level of tariff.' On Friday, several US-listed Swiss stocks fell. Shares of the country's biggest bank UBS Group AG slid 1.8% and computer hardware maker Logitech International SA dropped 3.5%. American depositary receipts for Compagnie Financière Richemont SA — owner of luxury maisons like Cartier, Chloé and Van Cleef & Arpels — fell 2.5%. And Watches of Switzerland Group Plc slumped 6.8% in London trading. What stings more is that Switzerland's European Union counterparts were able to secure a 15% tariff rate. That creates a 'competitive disadvantage' for the Swiss, according to a Friday note from authors including Daniel Kalt at UBS Global Wealth Management's Chief Investment Office. Last year, the US accounted for a 19% chunk of Switzerland's goods exports, the authors point out. Their base case is for the two countries to reach a similar tariff deal to the EU. But even then, they say a 15% tariff rate is still sizable compared to before 'Liberation Day,' while the US dollar's depreciation against the Swiss franc makes matters worse for Swiss exporters. For Holger Schmieding, chief economist at Germany's Berenberg, it's all a prelude to negotiations. 'It will be a big shock to the Swiss market initially, but this rate is so high it's more of a strategy to start serious negotiations rather than a final rate, which is likely to be much closer to the EU,' he said. Meanwhile, pharmaceutical heavyweights like Novartis AG and Roche Holding AG are facing additional pressure after Trump sent letters to 17 drugmakers last week, demanding lower prices. US and European peers initially dipped on the news. 'On top of the tariff strategy now comes a full-scale assault on the pricing of branded drugs sold in the U.S.,' wrote Arthur Jurus, Oddo BHF's head of investment office Switzerland. 'Trump is applying unprecedented pressure on drug prices, directly targeting Swiss pharmaceutical giants.' The Swiss Market Index has trailed the Stoxx 600 this year, partly because of its heavy exposure to defensive versus cyclical stocks. On Monday, the Swiss index could see a delayed reaction to its European peers, after the Stoxx 600 slumped 1.9% Friday for its worst day since April, while France's CAC 40, Germany's DAX and Italy's FTSE MIB fell over 2.5%. 'It's hard to tell whether this is the final say — or it's a negotiation tactic,' said Ipek Ozkardeskaya, senior analyst at Swissquote Group Holdings. 'Such tariffs will add additional pressure on Swiss exporters and cause further divergence of the SMI index from major peers.' Here's what other market participants are saying: Andrea Gabellone, head of global equities at KBC Global Securities 'This is hitting practically their core sectors — pharma, watches, chocolate, food. All those have already been hit by skyrocketing raw materials price and now this. So all the stars look misaligned for Swiss companies. The problem is they have a 39% tariff and on top of it, we have to see what happens to the pharma sector which is one of the top three in terms of Swiss exports.' Chris Beauchamp, chief market analyst at IG 'The high levels on Swiss imports mean investors will continue to sell first and ask questions later. No doubt the Swiss will be high-tailing it to Washington for a deal that should bring the level down, but for now the index faces a tough time indeed.' Ozge Brinkworth, healthcare analyst at Rathbones Investment Management, on the drug-pricing request 'The scope of the proposals is reasonably narrow, covering Medicaid products, which make up single digit percentage of sales for most major pharma companies, and new launches. Its implementation is also not straightforward, there has already been pushback from the Congress on Medicaid prices, and the US government's ability to influence drug prices in other countries is likely to be limited. Nevertheless these points do not prevent the continued threat of pricing reform from hurting the sentiment even more for the pharma and life sciences sectors.' --With assistance from Sagarika Jaisinghani, Julien Ponthus, Sujata Rao and Subrat Patnaik. How Podcast-Obsessed Tech Investors Made a New Media Industry Everyone Loves to Hate Wind Power. Scotland Found a Way to Make It Pay Off Russia Builds a New Web Around Kremlin's Handpicked Super App Cage-Free Eggs Are Booming in the US, Despite Cost and Trump's Efforts What's Really Behind Those Rosy GDP Numbers? ©2025 Bloomberg L.P. Sign in to access your portfolio

Who could lead Apple after Tim Cook
Who could lead Apple after Tim Cook

Yahoo

timean hour ago

  • Yahoo

Who could lead Apple after Tim Cook

There are no indications that Apple (AAPL) CEO Tim Cook is planning on leaving his role anytime soon. But the company's underwhelming AI developments have some questioning if it's time for new leadership. Yahoo Finance Tech Editor Dan Howley takes a closer look at some of the potential contenders. To watch more expert insights and analysis on the latest market action, check out more Market Domination. Good morning! Welcome to Apple Park. Apple may not be the powerhouse it's become without CEO Tim Cook. He served in the position since 2011, and has overseen the rollout of some of Apple's biggest products, including the iPhone 10, the launch of its TV streaming platform Apple TV Plus, and ushered in Apple's push into financial products with the Apple card. Now, the company faces pressure from Wall Street over its slow move into AI, and the search for its next big product post iPhone. This has led analysts at Lightshed Partners to question whether it's time for Cook to step aside and make way for a product focused CEO. Right now, there's no indication Cook is in danger of losing his job, but Cook is 64 years old, and despite his successes, he won't lead the company forever. Cook continues to be the Hall of Fame CEO. He will lead Apple, I believe at least the next five years. It wasn't that long ago that you could give Tim Cook credit as having created more value as a CEO than any other CEO in history. And we're talking about like two to three years ago. It's not that long ago. I think there's a sense that, you know, maybe some fresh blood in terms of the thinking within executive management would make some sense. That leaves the question of who will take up the reins of one of the most important technology companies in the world. Jeff Williams, Apple's previous COO, was once seen as Cook's potential successor, but he's retiring from the company later this year. Still, there's no shortage of top candidates at Apple who could take over for Cook. Craig Federighi, the company's senior vice president of software engineering, leads development of its Mac and iOS products. He also makes regular appearances at Apple's Worldwide Developers Conference, making him one of the most visible candidates in Apple's lineup. John Turnus is also a solid option as Apple's future CEO. He's been with the company since 2001 and has overseen the development of a number of products, including the iPad and AirPods. Perhaps more importantly, he's also been instrumental in Apple's move away from using Intel chips in its Macs to its own processors. Greg Joswiak, Apple's senior vice president of worldwide marketing, has worked at Apple since the late 1980s, giving him a wealth of knowledge about the company and its various products and services. Eddy Cue, Apple's senior vice president of services, currently leads the company's most important business segment outside of the iPhone. He's been with Apple since 1989, and brings the institutional knowledge necessary to navigate such a massive company. And then there's Deirdre O'Brien, Apple's senior vice president of people and retail. A 30 plus year Apple veteran, O'Brien brings along the experience and understanding of Apple's customer base that the company needs to ensure it's meeting user expectations. Cook's still on top for the foreseeable future, but it remains to be seen what Apple's leadership could look like down the road. Related Videos Amazon & Apple earnings: Takeaways from the tech giants' results Meta's hefty AI CapEx spend is already paying off, analyst says Microsoft is seeing big wins, including $4T market cap Meta and Microsoft earnings: What to watch for Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store